These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 29391000)
21. Characterization and in vitro studies of the anticancer effect of oxidized carbon nanotubes functionalized with betulinic acid. Tan JM; Karthivashan G; Arulselvan P; Fakurazi S; Hussein MZ Drug Des Devel Ther; 2014; 8():2333-43. PubMed ID: 25429205 [TBL] [Abstract][Full Text] [Related]
22. Synthesis, characterization and augmented anticancer potential of PEG-betulinic acid conjugate. Saneja A; Sharma L; Dubey RD; Mintoo MJ; Singh A; Kumar A; Sangwan PL; Tasaduq SA; Singh G; Mondhe DM; Gupta PN Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():616-626. PubMed ID: 28183653 [TBL] [Abstract][Full Text] [Related]
23. Multiple integrated computational approach to analyse wound healing potential of Rafey HA; Amin A; Ross SA; El-Shazly M; Zahid MA; Niaz SI; Ul Mahmood F; Ullah H Nat Prod Res; 2024 Mar; ():1-10. PubMed ID: 38497294 [TBL] [Abstract][Full Text] [Related]
24. Chemical Strategies towards the Synthesis of Betulinic Acid and Its More Potent Antiprotozoal Analogues. Cunha AB; Batista R; Castro MÁ; David JM Molecules; 2021 Feb; 26(4):. PubMed ID: 33670791 [TBL] [Abstract][Full Text] [Related]
26. Therapeutic applications of betulinic acid nanoformulations. Saneja A; Arora D; Kumar R; Dubey RD; Panda AK; Gupta PN Ann N Y Acad Sci; 2018 Jun; 1421(1):5-18. PubMed ID: 29377164 [TBL] [Abstract][Full Text] [Related]
27. Betulinic acid chemosensitizes breast cancer by triggering ER stress-mediated apoptosis by directly targeting GRP78. Cai Y; Zheng Y; Gu J; Wang S; Wang N; Yang B; Zhang F; Wang D; Fu W; Wang Z Cell Death Dis; 2018 May; 9(6):636. PubMed ID: 29802332 [TBL] [Abstract][Full Text] [Related]
28. Molecular interaction studies of amorphous solid dispersions of the antimelanoma agent betulinic acid. Yu M; Ocando JE; Trombetta L; Chatterjee P AAPS PharmSciTech; 2015 Apr; 16(2):384-97. PubMed ID: 25331193 [TBL] [Abstract][Full Text] [Related]
29. Quantitative structure-cytotoxicity relationship analysis of betulinic acid and its derivatives by semi-empirical molecular-orbital method. Ishihara M; Sakagami H; Liu WK Anticancer Res; 2005; 25(6B):3951-5. PubMed ID: 16309182 [TBL] [Abstract][Full Text] [Related]
30. Biological evaluation of a halogenated triterpenoid, 2α-bromo-dihydrobelulonic acid as inhibitor of human topoisomerase IIα and HeLa cell proliferation. Ghosh S; Mukhopadhyay S; Sarkar M; Mandal A; Das V; Kumar A; Giri B Chem Biol Interact; 2017 Apr; 268():68-76. PubMed ID: 28254521 [TBL] [Abstract][Full Text] [Related]
31. Biotechnological production of betulinic acid and derivatives and their applications. An T; Zha W; Zi J Appl Microbiol Biotechnol; 2020 Apr; 104(8):3339-3348. PubMed ID: 32112133 [TBL] [Abstract][Full Text] [Related]
32. Betulinic Acid-Nitrogen Heterocyclic Derivatives: Design, Synthesis, and Antitumor Evaluation Yang Y; Xie T; Tian X; Han N; Liu X; Chen H; Qi J; Gao F; Li W; Wu Q; Huo S; Gu Y; Dai Z; Wang P; Lei H Molecules; 2020 Feb; 25(4):. PubMed ID: 32093264 [TBL] [Abstract][Full Text] [Related]
33. Betulinic acid attenuates cyclophosphamide-induced intestinal mucosa injury by inhibiting the NF-κB/MAPK signalling pathways and activating the Nrf2 signalling pathway. Ou Z; Zhu L; Huang C; Ma C; Kong L; Lin X; Gao X; Huang L; Wen L; Liang Z; Yuan Z; Wu J; Yi J Ecotoxicol Environ Saf; 2021 Dec; 225():112746. PubMed ID: 34482064 [TBL] [Abstract][Full Text] [Related]
34. Attenuation of quorum sensing controlled virulence factors and biofilm formation in Pseudomonas aeruginosa by pentacyclic triterpenes, betulin and betulinic acid. Rajkumari J; Borkotoky S; Murali A; Suchiang K; Mohanty SK; Busi S Microb Pathog; 2018 May; 118():48-60. PubMed ID: 29526565 [TBL] [Abstract][Full Text] [Related]
35. Cytisine basicity, solvation, logP, and logD theoretical determination as tool for bioavailability prediction. Pieńko T; Grudzień M; Taciak PP; Mazurek AP J Mol Graph Model; 2016 Jan; 63():15-21. PubMed ID: 26609940 [TBL] [Abstract][Full Text] [Related]
36. Synthesis, Alam W; Khan H; Saeed Jan M; Rashid U; Abusharha A; Daglia M Front Chem; 2023; 11():1222047. PubMed ID: 37744065 [TBL] [Abstract][Full Text] [Related]
37. Recent progress on betulinic acid and its derivatives as antitumor agents: a mini review. Zhong Y; Liang N; Liu Y; Cheng MS Chin J Nat Med; 2021 Sep; 19(9):641-647. PubMed ID: 34561074 [TBL] [Abstract][Full Text] [Related]
38. Anti-AIDS agents. 78. Design, synthesis, metabolic stability assessment, and antiviral evaluation of novel betulinic acid derivatives as potent anti-human immunodeficiency virus (HIV) agents. Qian K; Yu D; Chen CH; Huang L; Morris-Natschke SL; Nitz TJ; Salzwedel K; Reddick M; Allaway GP; Lee KH J Med Chem; 2009 May; 52(10):3248-58. PubMed ID: 19388685 [TBL] [Abstract][Full Text] [Related]
39. Betulinic acid induces apoptosis and inhibits metastasis of human colorectal cancer cells in vitro and in vivo. Zeng A; Hua H; Liu L; Zhao J Bioorg Med Chem; 2019 Jun; 27(12):2546-2552. PubMed ID: 30910472 [TBL] [Abstract][Full Text] [Related]
40. A potent betulinic acid analogue ascertains an antagonistic mechanism between autophagy and proteasomal degradation pathway in HT-29 cells. Dutta D; Chakraborty B; Sarkar A; Chowdhury C; Das P BMC Cancer; 2016 Jan; 16():23. PubMed ID: 26772983 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]